17-43104139-G-C

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The ENST00000357654.9(BRCA1):​c.424C>G​(p.Pro142Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P142H) has been classified as Benign.

Frequency

Genomes: not found (cov: 32)

Consequence

BRCA1
ENST00000357654.9 missense

Scores

3
4
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.0560
Variant links:
Genes affected
BRCA1 (HGNC:1100): (BRCA1 DNA repair associated) This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.22985336).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
BRCA1NM_007294.4 linkuse as main transcriptc.424C>G p.Pro142Ala missense_variant 6/23 ENST00000357654.9 NP_009225.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
BRCA1ENST00000357654.9 linkuse as main transcriptc.424C>G p.Pro142Ala missense_variant 6/231 NM_007294.4 ENSP00000350283 P4P38398-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
33
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Hereditary cancer-predisposing syndrome Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJun 23, 2014The p.P142A variant (also known as c.424C>G and 543C>G), located in coding exon 5 of the BRCA1 gene, results from a C to G substitution at nucleotide position 424. The proline at codon 142 is replaced by alanine, an amino acid with highly similar properties. This variant was reported in a Lebanese breast cancer patient whose large family had many family members affected with breast and/or ovarian cancers (Jalkh N et al. Hered Cancer Clin Pract. 2012 Jun 19;10(1):7). This variant was not reported in population based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP), and 1000 Genomes Project. In the ESP, this variant was not observed in 6503 samples (13,006 alleles) with coverage at this position. To date, this alteration has been detected with an allele frequency of approximately 0.002% (greater than 42,000 alleles tested) in our clinical cohort (includes this individual). This amino acid position is moderately conserved in available vertebrate species. In addition, this alteration is predicted to be benign by PolyPhen but deleterious by SIFT in silico analyses. Since supporting evidence is limited at this time, the clinical significance of p.P142A remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.074
BayesDel_addAF
Pathogenic
0.27
D
BayesDel_noAF
Pathogenic
0.15
CADD
Benign
9.1
DANN
Benign
0.97
DEOGEN2
Benign
0.23
.;T;.;.;.;.;.;T;.;T;.;T;T;.;T;T
Eigen
Benign
-0.33
Eigen_PC
Benign
-0.48
FATHMM_MKL
Benign
0.11
N
LIST_S2
Uncertain
0.94
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
M_CAP
Pathogenic
0.36
D
MetaRNN
Benign
0.23
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
0.36
D
MutationAssessor
Uncertain
2.4
M;M;M;M;.;M;.;.;.;.;.;.;.;.;.;.
MutationTaster
Benign
1.0
N;N;N;N;N;N;N;N;N;N;N;N;N;N
PrimateAI
Benign
0.24
T
PROVEAN
Benign
-0.92
N;N;N;N;N;N;N;N;N;N;N;.;N;N;N;D
REVEL
Uncertain
0.61
Sift
Benign
0.040
D;D;D;D;D;D;D;T;D;D;D;.;D;D;D;T
Sift4G
Benign
0.83
T;T;T;T;T;T;.;.;T;.;D;.;D;.;D;.
Polyphen
0.82, 1.0, 1.0, 0.85
.;P;.;.;.;D;.;D;.;.;P;.;.;.;.;.
Vest4
0.33
MutPred
0.26
Loss of glycosylation at P142 (P = 0.0155);Loss of glycosylation at P142 (P = 0.0155);Loss of glycosylation at P142 (P = 0.0155);Loss of glycosylation at P142 (P = 0.0155);.;Loss of glycosylation at P142 (P = 0.0155);.;Loss of glycosylation at P142 (P = 0.0155);.;.;Loss of glycosylation at P142 (P = 0.0155);Loss of glycosylation at P142 (P = 0.0155);Loss of glycosylation at P142 (P = 0.0155);.;Loss of glycosylation at P142 (P = 0.0155);Loss of glycosylation at P142 (P = 0.0155);
MVP
0.86
MPC
0.12
ClinPred
0.22
T
GERP RS
-0.37
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.4
Varity_R
0.062
gMVP
0.32

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs397509156; hg19: chr17-41256156; API